Global Animal-derived Immune Globulin Products Market Research Report 2021
SKU ID :QYR-19356690 | Published Date: 18-Oct-2021 | No. of pages: 105Description
Immune globulin (Ig) short-term protection against hepatitis A and measles
The global Animal-derived Immune Globulin Products market was valued at US$ XX million in 2020 and is expected to reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027.
This report focuses on Animal-derived Immune Globulin Products volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Animal-derived Immune Globulin Products market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Animal-derived Immune Globulin Products Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
IVIg Liquid
IVIg Powder
Segment by Application
Immunodeficiency
Autoimmune Disease
Acute Infection
By Region
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Pfizer
Rare Disease Therapeutics
Instituto Bioclon
Merck & Co
Sanofi
Protherics
Genzyme Corporation
The global Animal-derived Immune Globulin Products market was valued at US$ XX million in 2020 and is expected to reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027.
This report focuses on Animal-derived Immune Globulin Products volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Animal-derived Immune Globulin Products market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Animal-derived Immune Globulin Products Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
IVIg Liquid
IVIg Powder
Segment by Application
Immunodeficiency
Autoimmune Disease
Acute Infection
By Region
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Pfizer
Rare Disease Therapeutics
Instituto Bioclon
Merck & Co
Sanofi
Protherics
Genzyme Corporation
TOC
Tables & Figures
Companies
- PRICE
-
$2900$5800$4350Buy Now